Advertisement
For stage I non-small-cell lung cancer

Lobectomy Beats SBRT Survival in Early-Stage NSCLC

0
Higher cancer mortality for SBRT versus lobectomy; no difference for SBRT, sublobar resection
From 1997 to 2014

Differences in Cancer Survival by Type of Insurance

0
Survival up in patients with private insurance, Medicare; no change or drop with other, no insurance
A decision pathway has been developed to guide management of acute bleeding in patients treated with oral anticoagulants; the decision pathway was published online Dec. 1 in the Journal of the American College of Cardiology.

ACC Guides Treatment of Bleeding With Oral Anticoagulation

0
Pathway supports clinician decision making during management of patients with bleeding complications
Certain clinical factors

Study IDs Clinical Factors Tied to Free Tissue Transfer Reoperation

0
Findings among patients undergoing free tissue transfer for head, neck cancer-related defects
Ogivri (trastuzumab-dkst) has been approved by the U.S. Food and Drug Administration as the nation's first biosimilar drug to treat certain breast and stomach cancers

FDA Approves Biosimilar Ogivri for Breast, Stomach Cancers

0
Ogivri is approved to treat HER2+ breast and gastric or gastroesophageal junction adenocarcinoma cancers
Urban American Indians and Alaskan Natives with cancer have a significantly higher comorbidity burden

Mortality Up for Some Cancers in Urban-Dwelling Native Americans

0
Urban American Indians and Alaskan Natives with cancer have significantly higher comorbidity burden
More than 5 percent of all incident cancers in 2012 were attributable to diabetes and high body mass index

Over 5 Percent of Incident Cancer Due to Diabetes, High BMI

0
In 2012, 5.6 percent of all incident cancers due to combined effects of diabetes, high BMI
Products marketed as selective androgen receptor modulators and sold via the internet frequently contain unapproved drugs and substances

Unapproved Drugs Identified in Androgen Receptor Modulators

0
Most of the 44 products sold via the internet contained unapproved drugs and substances
The Value-Based Payment Modifier is not associated with performance differences between practices serving higher-risk and lower-risk patients

Value-Based Payment Modifier Not Tied to Practice Performance

0
Performance differences between practices narrowed after adjustment for patient characteristics
Clinician denial of some types of tests requested by patients is associated with worse patient satisfaction with the clinician

Clinician Denial of Patient Requests Impacts Satisfaction

0
Worse satisfaction in association with denial of request for referral, pain meds, other meds, lab tests